editor
read
great
anticip
american
academi
dermatolog
recent
public
guidanc
use
biolog
agent
outbreak
although
immunopathophysiolog
behind
guidelin
remain
investig
exist
concept
may
elucid
agent
requir
extra
precaut
mitig
coronaviru
diseas
morbid
key
aspect
risk
mitig
prevent
infect
atrisk
popul
current
evid
suggest
popul
includ
older
adult
seriou
chronic
medic
condit
immunosuppress
patient
prior
activ
cancer
whether
last
group
includ
patient
receiv
biolog
smallmolecul
therapi
remain
seen
nevertheless
therapeut
efficaci
immunosuppress
immunomodulatori
medic
critic
manag
inflammatori
autoimmun
condit
dermatolog
inde
understand
physiolog
mechan
agent
aid
discuss
patient
tcell
immun
critic
host
defens
viral
pathogen
antivir
tcell
respons
initi
uptak
viral
antigen
infect
tissu
activ
cell
viral
recognit
pathogen
signal
cytokin
polar
toward
thelper
th
profil
via
interleukin
il
type
interferon
importantli
regulatori
treg
tcell
popul
may
also
gener
degre
combat
infect
certain
viral
pathogen
stand
reason
use
biolog
therapi
known
modul
blunt
respons
includ
tumor
necrosi
factorinhibitor
abatacept
inhibitor
ustekinumab
inhibitor
may
specif
requir
stringent
precaut
diminish
risk
infect
priorit
altern
therapeut
agent
possibl
effect
inhibitor
dupilumab
blockad
predomin
impair
pathway
pathway
respect
remain
unknown
also
warrant
caution
addit
use
nonbiolog
system
therapi
cyclosporin
azathioprin
methotrex
warrant
similar
precaut
therapeut
mechan
creat
state
gener
immunosuppress
host
clinic
data
also
paradox
suggest
deterior
infect
patient
may
result
proinflammatori
state
creat
cytokin
storm
similar
pathogenesi
implic
diseas
biolog
sarscov
merscov
infect
specif
higher
concentr
gcsf
tumor
necrosi
factor
found
patient
requir
intens
care
unit
admiss
compar
infect
requir
intens
care
unit
admiss
suggest
possibl
associ
cytokin
storm
diseas
sever
cytokin
storm
immunopatholog
suggest
subset
immunosuppress
therapi
may
begin
play
protect
role
infect
patient
inhibit
intens
cytokin
storm
immunosuppress
may
prevent
lung
tissu
damag
clinic
deterior
directli
counteract
cytokin
storm
glucocorticoid
treatment
activ
investig
china
therapi
similarli
investig
combat
morbid
influenza
viru
pandem
similar
mechan
may
becom
import
clinic
evid
collect
inform
evidencedbas
guidelin
manag
dermatologist
use
clinic
judgement
exist
american
academi
dermatolog
guidelin
understand
pathophysiolog
determin
appropri
risk
benefit
use
system
immunomodul
therapi
